Techcyte

Orem, United States Founded: 2014 • Age: 12 yrs
AI-based image analysis is provided for pathologists digital microscopy.

About Techcyte

Techcyte is a Healthcare company based in Orem (United States) founded in 2014. It operates as an AI-based image analysis is provided for pathologists digital microscopy. Techcyte has raised $65.4 million across 6 funding rounds from investors including Zoetis, ARUP Laboratories and Mayo Clinic. Techcyte offers products and services including Fusion, SureView Cervical Cytology System, Frozen Section Suite, Parasitology Suite, and Bacteriology Suite. Its focus areas include HealthTech, Clinical Labs IT, Pathology and Image Analysis. Its legal entity is Techcyte, Inc. Its competitors include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics and 4 more; 9 of its 9 listed competitors have raised funding.

Company details

Techcyte was founded in 2014 in Orem, United States, within the healthcare technology sector. Digital microscopy images are analyzed through multiple AI platforms tailored for pathologists. Development focuses on tools for hematology tests, cervical cytology, and ova and parasites fecal examinations, applicable to both human and animal samples. A collaboration with Motic integrates whole slide scanning, workflow management, and reporting functionalities.

  • Headquarters Orem, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website techcyte.com
  • Social LinkedIn X Facebook
  • Legal Name Techcyte, Inc.
Key Metrics
  • Total Equity Funding
    $65.4M (USD)

    in 6 rounds

  • Latest Funding Round
    $15M (USD), Series B

    Apr 2026

  • Investors
    Zoetis

    & 2 more

Products & Services of Techcyte

Techcyte offers a comprehensive portfolio of products and services, including Fusion, SureView Cervical Cytology System, Frozen Section Suite, Parasitology Suite, and Bacteriology Suite.

Fusion
Digital Pathology Platform

Unified platform for clinical and anatomic pathology workflows.

SureView Cervical Cytology System
Cytology Analysis

AI-based system for detecting cervical cytology abnormalities.

Frozen Section Suite
Pathology Tool

AI-assisted tool for rapid frozen section analysis in diagnostics.

Parasitology Suite
Microbiology Tool

Platform for AI-driven detection of parasites in samples.

Bacteriology Suite
Microbiology Analysis

AI system for gram analysis and bacterial identification.

Funding Insights of Techcyte

Techcyte has successfully raised a total of $65.4M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $65.4M
  • Total Rounds 6
  • Last Round Series B β€” $15M
  • First Round $1.7M

    (Jun 2016)

  • Investors Count 3

All 6 funding rounds of Techcyte with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2026$15MSeries B––
Apr 2026$15MSeries B––
Dec 2023$8.4MSeries B––
–
Aug 2021$21MSeries B–Zoetis, ARUP Laboratories
–
Jan 2018$4.3MSeries A––
–
Jun 2016$1.7MSeed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Techcyte

Techcyte has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Zoetis, ARUP Laboratories and Mayo Clinic.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
2012zoetis.comBrussels, Belgium
Clinical laboratory testing and healthcare advisory services are provided.
1999aruplab.comSalt Lake City, United States
-
–mayoclinic.org-
Premium access

Investor details for Techcyte

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Techcyte

38 people are tracked at Techcyte (12 in leadership, 26 in team).

NameRoleGroup
Bryce Lovell
Director of EngineeringLeadership
Ben Cahoon
Chief Executive OfficerLeadership
Marcus Malmberg
VP of Regulatory AffairsLeadership
Matt Smith
Chief Strategy Officer (CSO)Leadership
Shane Swenson
Chief Technology OfficerLeadership
Bryan Worthen
VP Of PlatformLeadership
Taylor Smith
Chief Financial OfficerLeadership
Jacob R. Hicks
Vice President Of SalesLeadership
Travis Taylor
Director Of Infrastructure And SecurityLeadership
Falon Gray Markow
Director of Data ManagementLeadership
Matthew Yarro
Director Of User Training And DocumentationLeadership
Zach Bradshaw
Director Of SupportLeadership
Ashley Elena G.
Senior Software EngineerTeam
John Walker
Senior Systems Engineer / Technical Product ManagerTeam
Paul Cram
Senior DeveloperTeam
Robert Glover
Senior Software EngineerTeam
Skip Breidbach
Senior Software EngineerTeam
Clinton Wadley
Senior Software EngineerTeam
Addy V.
Senior Quality Assurance EngineerTeam
Jonathan Lowthert
Senior Software EngineerTeam

18 more people are available in the full profile.

Premium access

Complete people profiles for Techcyte

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Techcyte

3 dated milestones of Techcyte across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Techcyte is founded.
  2. Funding First funding round of $1.7M.
  3. Funding Latest funding round, Series B, of $15.0M.

Competitors of Techcyte

Techcyte has 9 listed competitors in our database, 9 of them funded. They include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pathai.com2016Boston, United States$254.94M573
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
viz.ai2016San Francisco, United States$251.99M206
AI and cloud-powered software for stroke care coordination is developed.
deepcell.com2015Mountain View, United States$122.99M94
AI-powered single cell classification and isolation technology for clinical research
deciphex.com2017Dublin, Ireland$56.65M–
Digital pathology software is developed for clinical and veterinary productivity.
aignostics.com2018Berlin, Germany$53.89M25
AI-based pathology diagnostic software is provided for medical analysis.
pictorlabs.ai2019Los Angeles, United States$48.83M–
AI-based tools for pathological image analysis are provided to labs.
paige.ai2018New York, United States$241M–
AI-enabled tools for computational pathology and cancer diagnostics are provided.
nekohealth.com2018Stockholm, Sweden$325.38M–
Platform offering solutions for preventive health scans
proscia.com2014Philadelphia, United States$129.23M85
Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
Premium access

Detailed competitors of Techcyte

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Techcyte

The website of Techcyte (techcyte.com) receives about 6.7K visits a month.

  • Monthly visits
    6.7K

    ▲ 54.4% vs previous month

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Techcyte (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Techcyte

Premium access

Complete news archive for Techcyte

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Techcyte

Techcyte was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Techcyte is headquartered in Orem, United States. It is registered at Orem, Utah, United States.

Techcyte is a funded company, having raised a total of $65.4M across 6 funding rounds to date. The company's 1st funding round was a Seed of $1.7M, raised on Jun 2016.

Techcyte was founded in 2014 in Orem, United States, within the healthcare technology sector. Digital microscopy images are analyzed through multiple AI platforms tailored for pathologists. Development focuses on tools for hematology tests, cervical cytology, and ova and parasites fecal examinations, applicable to both human and animal samples. A collaboration with Motic integrates whole slide scanning, workflow management, and reporting functionalities.

Techcyte's top competitors include Aignostics, Deciphex and Pictor Labs.

Techcyte offers Fusion, SureView Cervical Cytology System, Frozen Section Suite, Parasitology Suite, and Bacteriology Suite.

Techcyte has 3 investors. Key investors include Zoetis, ARUP Laboratories, and Mayo Clinic.

Techcyte operates through Techcyte, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available